Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection

Journal of Clinical Virology

Volumn 58, Issue 2, 2013, Pages 461-467

  Delarue, Séverine ^a   Didier, Emmanuelle ^a   Damond, Florence ^b   Ponscarme, Diane ^a   Brengle Pesce, Karen ^c   Resche Rigon, Matthieu ^a   Vray, Muriel ^d   Gueudin, Marie ^e   Simon, François ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c BioMérieux   (France)

^d INSTITUT PASTEUR   (France)

^e ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

HIV 2; Natural history; Viral load

Indexed keywords

REAGENT; RNA;

ARTICLE; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; LIMIT OF DETECTION; PLASMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD;

HIV-2; NATURAL HISTORY; VIRAL LOAD;

DNA PRIMERS; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-2; HUMANS; OLIGONUCLEOTIDE PROBES; PLASMA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

EID: 84884530129     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.08.003     Document Type: Article

References (27)

1. Cazein F., Lot F., Pillonel J., Pinget R., Bousquet V., Le Strat Y., et al. Surveillance de l'infection à VIH-sida en France, 2009. Bulletin d'Epidémiologie Hebdomadaire 2010, 45-46. http://www.invs.sante.fr/surveillance/vih-sida/publications_do.htm.
2. Poulsen A.G., Aaby P., Jensen H., Dias F. Risk factors for HIV-2 seropositivity among older people in Guinea-Bissau. A search for the early history of HIV-2 infection. Scand J Infect Dis 2000, 32:169-175.
3. Shanmugam V., Switzer W.M., Nkengasong J.N., García-Lerma G., Green T.A., Ekpini E., et al. Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections. J Acquir Immune Defic Syndr 2000, 24:257-263.
4. Drylewicz J., Matheron S., Lazaro E., Damond F., Bonnet M., Simon F., et al. Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France. AIDS 2008, 22:457-468.
5. Valadas E., França L., Sousa S., Antunes F. 20 years of HIV-2 infection in Portugal: trends and changes in epidemiology. Clin Infect Dis 2009, 48:1166-1167.
6. Simon F., Matheron S., Tamalet C., Loussert-Ajaka L., Bartczak S., Pepin J.M., et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993, 7:1411-1417.
7. Berry N., Ariyoshi K., Jobe O., Ngum P.T., Corrah T., Wilkins A., et al. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res Hum Retroviruses 1994, 10:1031-1037.
8. Gottlieb G.S., Sow P.S., Hawes S.E., Ndoye I., Redman M., Coll-Seck A.M., et al. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis 2002, 185(7):905-914.
9. MacNeil A., Sarr A.D., Sankale J.L., Meloni S.T., Mboup S., Kanki P. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J Virol 2007, 81:5325-5330.
10. Adje Toure C.A., Cheingsong R., Garcìa Lerma J.G., Eholié S., Borget M.Y., Bouchez J.M., et al. Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, CÔte d'Ivoire. AIDS 2003, 17(Suppl. 3):49-54.
11. Yeni P. Prise en charge médicale des personnes infectées par le VIH. Recommandations du groupe d'experts. Ministère de la santé et des sports. La documentation Française 2010, 242-245.
12. Damond F., Gueudin M., Pueyo S., Farfara I., Robertson D.L., Descamps D., et al. Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections. J Clin Microbiol 2002, 40:3654-3659.
13. Chang M., Gottlieb G.S., Dragavon J.A., Cherne S.L., Kenney D.L., Hawes S.E., et al. Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform. J Clin Virol 2012, 55(2):128-133.
14. Rodes B., Sheldon J., Toro C., Cuevas L., Perez Pastrana E., Herrera I., et al. Quantitative detection of plasma human immunodeficiency virus type 2 subtype A RNA by the Nuclisens EasyQ Assay (version 1.1). J Clin Microbiol 2007, 45:88-92.
15. Braun J., Plantier J.C., Hellot M.F., Tuaillon E., Gueudin M., Damond F., et al. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS 2003, 17(3):331-336.
16. Damond F., Benard A., Balotta C., Boni J., Cotten M., Duque V., et al. ACHI(E)V(2E) Study Group An international collaboration to standardize HIV-2viral load assays: results from the 2009 ACHI(E)V(2E) quality control study. J Clin Microbiol 2011, 49(10):3491-3497.
17. Morris C., Berry N., Heath A., Holmes H. Preparation and evaluation of a proposed 1st International Standard for HIV-2 RNA World Health organization expert committee on biological standardization? 2009, http://www.nibsc.ac.uk/PDF/HIV-2_IS.pdf.
18. Gao F., Yue L., Robertson D.L., Hill S.C., Hui H., Biggar R.J., et al. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994, 68:7433-7447.
19. Chen Z., Telfier P., Gettie A., Reed P., Zhang L., Ho D.D., et al. Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop. J Virol 1996, 70(6):3617-3627.
20. Chen Z., Luckay A., Sodora D.L., Telfer P., Reed P., Gettie A., et al. Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J Virol 1997, 71:3953-3960.
21. Yamaguchi J., Devare S.G., Brennan C.A. Identification of a new HIV-2 subtype based on phylogenetic analysis of full-length genomic sequence. AIDS Res Hum Retroviruses 2000, 16(9):925-930.
22. Smith S.M., Christian D., De Lame V., Shah U., Austin L., Gautam R., et al. Isolation of a new HIV-2 group in the US. Retrovirology 2008, 5:103.
23. Damond F., Collin G., Descamps D., Matheron S., Pueyo S., Taieb A., et al. Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay. J Clin Microbiol 2005, 43:4234-4236.
24. Gueudin M., Damond F., Simon F. Quantification of proviral DNA load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR. Methods Mol Biol 2005, 304:215-220.
25. Gallagher M.L., Burke W.F., Orzech K. Carrier RNA enhancement of recovery of DNA from dilute solutions. Biochem Biophys Res Commun 1987, 144:271-276.
26. Witt D.J., Kemper M. Techniques for the evaluation of nucleic acid amplification technology performance with specimens containing interfering substances: efficacy of boom methodology for extraction of HIV-1 RNA. J Virol Methods 1999, 79:97-111.
27. Damond F., Apetrei C., Robertson D.L., Souquiere S., Lepretre A., Matheron S., et al. Variability of Human Immunodeficiency Virus Type 2 (HIV-2) infecting patients living in France. Virology 2001, 280(1):19-30.